Fabrication and initial testing of the μDBS: a novel Deep Brain Stimulation electrode with thousands of individually controllable contacts

Verfasser / Beitragende:
[Andrew Willsie, Alan Dorval]
Ort, Verlag, Jahr:
2015
Enthalten in:
Biomedical Microdevices, 17/3(2015-06-01), 1-12
Format:
Artikel (online)
ID: 605479763
LEADER caa a22 4500
001 605479763
003 CHVBK
005 20210128100411.0
007 cr unu---uuuuu
008 210128e20150601xx s 000 0 eng
024 7 0 |a 10.1007/s10544-015-9961-x  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10544-015-9961-x 
245 0 0 |a Fabrication and initial testing of the μDBS: a novel Deep Brain Stimulation electrode with thousands of individually controllable contacts  |h [Elektronische Daten]  |c [Andrew Willsie, Alan Dorval] 
520 3 |a High frequency electrical stimulation of deep brain structures such as the subthalamic nucleus in Parkinson's disease or thalamus for essential tremor is used clinically to reduce symptom severity. Deep brain stimulation activates neurons in specific brain structures and connection pathways, overriding aberrant neural activity associated with symptoms. While optimal deep brain stimulation might activate a particular neural structure precisely, existing deep brain stimulation can only generate roughly-spherical regions of activation that do not overlap with any target anatomy. Additionally, side effects linked to stimulation may be the result of limited control over placement of stimulation and its subsequent spread out of optimal target boundaries. We propose a novel lead with thousands of individually controllable contacts capable of asymmetric stimulation profiles. Here we outline the design motivation, manufacturing process, and initial testing of this new electrode design, placing it on track for further directional stimulation studies. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Deep brain stimulation  |2 nationallicence 
690 7 |a Current steering  |2 nationallicence 
690 7 |a Microelectrode array  |2 nationallicence 
690 7 |a Parkinson's disease  |2 nationallicence 
700 1 |a Willsie  |D Andrew  |u University of Utah, 84112, Salt Lake City, UT, USA  |4 aut 
700 1 |a Dorval  |D Alan  |u University of Utah, 84112, Salt Lake City, UT, USA  |4 aut 
773 0 |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/3(2015-06-01), 1-12  |x 1387-2176  |q 17:3<1  |1 2015  |2 17  |o 10544 
856 4 0 |u https://doi.org/10.1007/s10544-015-9961-x  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10544-015-9961-x  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Willsie  |D Andrew  |u University of Utah, 84112, Salt Lake City, UT, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Dorval  |D Alan  |u University of Utah, 84112, Salt Lake City, UT, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biomedical Microdevices  |d Springer US; http://www.springer-ny.com  |g 17/3(2015-06-01), 1-12  |x 1387-2176  |q 17:3<1  |1 2015  |2 17  |o 10544